In a recent interview with Alejandro Cremades, Axent Bio co-founder David Schaffer shared his journey from academic scientist to serial biotech entrepreneur. His reflections offer a clear picture of the values that shape Axent today.
From building startups out of UC Berkeley and QB3, to founding multiple biotech ventures—including 4D Molecular Therapeutics—David emphasizes the power of translating science into real-world therapies. He spoke candidly about taking calculated risks, learning from seasoned entrepreneurs, and building ecosystems that support innovation at scale.
At Axent, we carry that same vision forward—bridging rigorous science with practical impact in cell therapy and regenerative medicine.
